SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-268875
Filing Date
2023-11-02
Accepted
2023-11-02 08:11:30
Documents
14
Period of Report
2023-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d559627d8k.htm   iXBRL 8-K 25649
2 EX-99.1 d559627dex991.htm EX-99.1 56140
6 GRAPHIC g559627g1101071752442.jpg GRAPHIC 2541
  Complete submission text file 0001193125-23-268875.txt   215561

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alvr-20231102.xsd EX-101.SCH 2850
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alvr-20231102_lab.xml EX-101.LAB 17978
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alvr-20231102_pre.xml EX-101.PRE 11258
8 EXTRACTED XBRL INSTANCE DOCUMENT d559627d8k_htm.xml XML 3334
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

IRS No.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39409 | Film No.: 231370199
SIC: 2836 Biological Products, (No Diagnostic Substances)